Revolution Medicines, Inc. RVMD Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s change in lease liabilities?
- Revolution Medicines, Inc. (RVMD) reported change in lease liabilities of -$2.07M in Q1 2026.
- How has Revolution Medicines, Inc.'s change in lease liabilities changed year-over-year?
- Revolution Medicines, Inc.'s change in lease liabilities decreased by 38.1% year-over-year, from -$1.5M to -$2.07M.
- What does change in lease liabilities mean?
- The net change in the company's long-term obligations for leased property.
- How do you interpret change in lease liabilities?
- An increase reflects new lease commitments or expansions, while a decrease indicates the reduction of lease obligations.
- How does change in lease liabilities compare across companies?
- Standardized under ASC 842; comparable across all companies with significant real estate footprints.